Author
Dave Ricks
Dave Ricks is chairman and chief executive officer of Eli Lilly and Company. He was elected chairman of the company’s board effective June 2017.
Dave Ricks Shares About Lilly's FDA Emergency Use Authorization for a Neutralizing Antibody
View Story
CEO Dave Ricks Shares Lilly's Principles of COVID-19 Antibody Therapy Pricing and Access
View Story
Committing to the Indy Racial Equity Pledge
View Story
Amid COVID-19 Crisis, Lilly Introduces $35 Co-Pay for Insulin
View Story
To the Millions of Americans Who Rely on Lilly Insulin
View Story
Dave Ricks Shares Thoughts on 2019
View Story
Changing the Math on Alzheimer’s
View Story
A Catalyst for More Affordable Medicines
View Story
New Prescription for Americans’ Drug Costs
View Story